These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28069603)

  • 1. Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy.
    Chauvet S; Frémeaux-Bacchi V; Petitprez F; Karras A; Daniel L; Burtey S; Choukroun G; Delmas Y; Guerrot D; François A; Le Quintrec M; Javaugue V; Ribes D; Vrigneaud L; Arnulf B; Goujon JM; Ronco P; Touchard G; Bridoux F
    Blood; 2017 Mar; 129(11):1437-1447. PubMed ID: 28069603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies.
    Caravaca-Fontán F; Lucientes L; Serra N; Cavero T; Rodado R; Ramos N; Gonzalez F; Shabaka A; Cabello V; Huerta A; Pampa-Saico S; Gutiérrez E; Quintana LF; López-Rubio ME; Draibe J; Alonso Titos J; Fernández-Juárez G; Goicoechea de Jorge E; Praga M
    Nephrol Dial Transplant; 2022 Oct; 37(11):2128-2137. PubMed ID: 34677610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3 glomerulopathy associated with monoclonal Ig is a distinct subtype.
    Ravindran A; Fervenza FC; Smith RJH; Sethi S
    Kidney Int; 2018 Jul; 94(1):178-186. PubMed ID: 29729982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy.
    Chauvet S; Roumenina LT; Aucouturier P; Marinozzi MC; Dragon-Durey MA; Karras A; Delmas Y; Le Quintrec M; Guerrot D; Jourde-Chiche N; Ribes D; Ronco P; Bridoux F; Fremeaux-Bacchi V
    Front Immunol; 2018; 9():2260. PubMed ID: 30333829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three cases of monoclonal gammopathy of renal significance after kidney transplantation. De novo C3 glomerulopathy.
    Serra N; Facundo C; Canal C; Arce Y; Ayasreh N; Vila A; Bardají B; Silva I; López V; Benito S; Ballarín J; Guirado L
    Nefrologia (Engl Ed); 2019; 39(2):198-201. PubMed ID: 29914760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update to the pathogenesis for monoclonal gammopathy of renal significance.
    Zuo C; Zhu Y; Xu G
    Ann Hematol; 2020 Apr; 99(4):703-714. PubMed ID: 32103323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients.
    Chauvet S; Bridoux F; Ecotière L; Javaugue V; Sirac C; Arnulf B; Thierry A; Quellard N; Milin S; Bender S; Goujon JM; Jaccard A; Fermand JP; Touchard G
    Am J Kidney Dis; 2015 Nov; 66(5):756-67. PubMed ID: 25987261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report.
    Hirashio S; Satoh A; Arima T; Mandai K; Awaya T; Oshima K; Hara S; Masaki T
    BMC Nephrol; 2018 May; 19(1):108. PubMed ID: 29724182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
    Sethi S; Fervenza FC; Rajkumar SV
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update to the pathogenesis for monoclonal gammopathy of renal significance.
    Zuo C; Zhu Y; Xu G
    Crit Rev Oncol Hematol; 2020 May; 149():102926. PubMed ID: 32199132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Monoclonal Gammopathy-associated C3 Glomerulopathy With Daratumumab-based Therapy.
    Coltoff A; Bomback A; Shirazian S; Lentzsch S; Bhutani D
    Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e674-e677. PubMed ID: 34023209
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose melphalan and autologous hematopoietic stem cell transplant in patient with C3 glomerulonephritis associated with monoclonal gammopathy
.
    Lepori N; Cheungpasitporn W; Sethi S; Murray D; Kumar S; Leung N; Giridhar KV; Fervenza FC
    Clin Nephrol; 2018 Apr; 89(4):291-299. PubMed ID: 29249234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eculizumab as salvage therapy for recurrent monoclonal gammopathy-induced C3 glomerulopathy in a kidney allograft.
    Moog P; Jost PJ; Büttner-Herold M
    BMC Nephrol; 2018 May; 19(1):106. PubMed ID: 29724174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report.
    Alonso-Titos J; Perea-Ortega L; Sola E; Torres-Rueda A; León M; Toledo R; Duarte AD; Vazquez T; Martinez-Esteban MD; Bailen A; Ruiz-Esteban P; Hernandez D
    BMC Nephrol; 2018 Jun; 19(1):129. PubMed ID: 29884135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.
    Sethi S; Rajkumar SV; D'Agati VD
    J Am Soc Nephrol; 2018 Jul; 29(7):1810-1823. PubMed ID: 29703839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a nation-wide cohort study suggest favorable long-term outcomes of clone-targeted chemotherapy in immunotactoid glomerulopathy.
    Javaugue V; Dufour-Nourigat L; Desport E; Sibille A; Moulin B; Bataille P; Bindi P; Garrouste C; Mariat C; Karlin L; Nouvier M; Goujon JM; Gnemmi V; Fermand JP; Touchard G; Bridoux F
    Kidney Int; 2021 Feb; 99(2):421-430. PubMed ID: 32739419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic.
    Ravindran A; Fervenza FC; Smith RJH; De Vriese AS; Sethi S
    Mayo Clin Proc; 2018 Aug; 93(8):991-1008. PubMed ID: 30077216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy.
    Le Quintrec M; Lapeyraque AL; Lionet A; Sellier-Leclerc AL; Delmas Y; Baudouin V; Daugas E; Decramer S; Tricot L; Cailliez M; Dubot P; Servais A; Mourey-Epron C; Pourcine F; Loirat C; Frémeaux-Bacchi V; Fakhouri F
    Am J Kidney Dis; 2018 Jul; 72(1):84-92. PubMed ID: 29429752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case Series.
    Heybeli C; Alexander MP; Bentall AJ; Amer H; Buadi FK; Dean PG; Dingli D; Dispenzieri A; El Ters M; Gertz MA; Issa NS; Kapoor P; Kourelis T; Kukla A; Kumar S; Lacy MQ; Lorenz EC; Muchtar E; Murray DL; Nasr SH; Prieto M; Rajkumar SV; Schinstock CA; Stegall MD; Warsame R; Leung N
    Am J Kidney Dis; 2022 Feb; 79(2):202-216. PubMed ID: 34175375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.